Interestingly, in the primary tumor, CD206+ macrophages were significantly reduced after anti-IL-25 antibody treatment (Fig. 5A), which were reported to promote tumor growth and metastasis (Van Dyken and Locksley, 2013). Here, IL25 is linked to neoplasm.